APT Medical Inc. (SHA:688617)

Market Cap	27.05B -32.9%
Revenue (ttm)	2.72B +25.2%
Net Income	866.92M +21.1%
EPS	6.13 +21.0%
Shares Out	141.13M
PE Ratio	31.27
Forward PE	24.64
Dividend	1.00 (0.52%)
Ex-Dividend Date	May 14, 2026

Volume	1,812,403
Open	194.03
Previous Close	196.40
Day's Range	191.56 - 197.38
52-Week Range	190.51 - 337.20
Beta	-0.43
Analysts	Strong Buy
Price Target	335.39 (+75.01%)
Earnings Date	Aug 21, 2026

About APT Medical

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories. The company also manufactures and supplies EP and vascular intervention medical devices. In addit...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 3,118
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2025, APT Medical's revenue was 2.58 billion, an increase of 25.08% compared to the previous year's 2.07 billion. Earnings were 820.64 million, an increase of 21.91%.

Analyst Summary

According to 9 analysts, the average rating for 688617 stock is "Strong Buy." The 12-month stock price target is ¥335.39, which is an increase of 75.01% from the latest price.

Price Target

¥335.39

(75.01% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error